| 000 | 01716 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513223736.0 | ||
| 264 | 0 | _c20010111 | |
| 008 | 200101s 0 0 eng d | ||
| 022 | _a1058-4838 | ||
| 024 | 7 |
_a10.1086/317471 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartino, R | |
| 245 | 0 | 0 |
_aToxoplasmosis after hematopoietic stem cell transplantation. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cNov 2000 |
||
| 300 |
_a1188-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntiprotozoal Agents |
| 650 | 0 | 4 | _aAutopsy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aClindamycin _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPyrimethamine |
| 650 | 0 | 4 |
_aSulfadiazine _xtherapeutic use |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aToxoplasma _xisolation & purification |
| 650 | 0 | 4 |
_aToxoplasmosis _xdiagnosis |
| 650 | 0 | 4 |
_aTrimethoprim, Sulfamethoxazole Drug Combination _xtherapeutic use |
| 700 | 1 | _aMaertens, J | |
| 700 | 1 | _aBretagne, S | |
| 700 | 1 | _aRovira, M | |
| 700 | 1 | _aDeconinck, E | |
| 700 | 1 | _aUllmann, A J | |
| 700 | 1 | _aHeld, T | |
| 700 | 1 | _aCordonnier, C | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 31 _gno. 5 _gp. 1188-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/317471 _zAvailable from publisher's website |
| 999 |
_c11015539 _d11015539 |
||